Medicare Rx Payment Method Deters Hospital Use Of High-Cost Drugs – BIO
Executive Summary
Basing Medicare reimbursement for hospital-administered drugs on a single cost-to-charge ratio will lead hospitals to stop providing higher cost drugs and biological products, Alkermes CEO Richard Pops told the Senate Appropriations/HHS Subcommittee Jan. 30
You may also be interested in...
Generic Biologics Are Coming, Commissioner McClellan Tells MBC
Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council
Generic Biologics Are Coming, Commissioner McClellan Tells MBC
Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council
Medicare “Inherent Reasonableness” Standard Should Be Clarified, BIO Says
The Centers for Medicare & Medicaid Services should clarify its guidelines for applying the "inherent reasonableness" standard to coverage decisions, the Biotechnology Industry Organization says